Population studies of methicillin-resistant and -sensitive Staphylococcus aureus strains reveal a lack of variability in the agrD gene, encoding a staphylococcal autoinducer peptide by Nieuwenhuizen, W. van et al.
JOURNAL OF BACTERIOLOGY,
0021-9193/00/$04.0010
Oct. 2000, p. 5721–5729 Vol. 182, No. 20
Copyright © 2000, American Society for Microbiology. All Rights Reserved.
Population Studies of Methicillin-Resistant and -Sensitive
Staphylococcus aureus Strains Reveal a Lack of Variability in
the agrD Gene, Encoding a Staphylococcal Autoinducer Peptide
WILLEM VAN LEEUWEN,* WENDY VAN NIEUWENHUIZEN, CHRISTEL GIJZEN, HENRI VERBRUGH,
AND ALEX VAN BELKUM
Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center Rotterdam,
Rotterdam, The Netherlands
Received 18 May 2000/Accepted 26 July 2000
The virulence of Staphylococcus aureus is controlled by the accessory gene regulator (agr) system, including
an extracellular inducer encoded by agrD. Variable agr PCR restriction fragment length polymorphism (RFLP)
patterns of unique S. aureus strains (n 5 192) were determined for a region comprising agrD and parts of the
neighboring agrC and agrB genes. Twelve unique RFLP patterns were identified among S. aureus strains in
general; these patterns were further specified by sequencing. All sequences could be catalogued in the three
current agr groups. A major proportion of the S. aureus strains belong to agr group 1, whereas only 6% of the
methicillin-susceptible S. aureus strains and 5% of the methicillin-resistant S. aureus strains belong to agr
groups 2 and 3, respectively. The homology between groups varied from 75 to 80%, and within groups it varied
from 96 to 100%. Different levels of sequence variability were observed in the different agr genes. agr-related
bacterial interference among colonizing S. aureus strains in the noses of persistent and intermittent human
carriers was studied. S. aureus strains belonging to different agr groups were encountered in the same
individual. This may suggest that the activity of the agrD gene product does not define colonization dynamics,
which is further substantiated by the rarity of agr group 2 and 3 strains.
Staphylococcus aureus is a major human pathogen, causing a
wide range of diseases including septicemia, meningitis, endo-
carditis, osteomyelitis, septic arthritis, toxic shock syndrome,
and food poisoning (20). The pathogenic diversity of the bac-
terium reflects its ability to successfully survive in many differ-
ent host tissues during infection. The pathogenic capacity of S.
aureus is clearly dependent on its production of exoproteins.
The synthesis of these virulence factors is globally regulated by
an S. aureus quorum-sensing system called the accessory gene
regulator (agr). The expression of genes in agr varies in re-
sponse to changes in cell density (15). This global regulatory
system utilizes a posttranscriptionally modified signal peptide
that is excised from the AgrD peptide. This thiolactone-con-
taining peptide accumulates in the external environment dur-
ing postexponential growth of the S. aureus population. It is
postulated that the signal peptide interacts with the transmem-
brane receptor protein (AgrC) of a classical two-component
regulatory system (AgrC, AgrA) that in turn activates the tran-
scription of the agr locus (5, 9). This induces the down-regu-
lation of genes encoding surface proteins and the up-regula-
tion of genes encoding secreted virulence factors (2, 5).
Ji et al. (4) recently described interference among different
strains of staphylococci with regard to synthesis of their viru-
lence factors and other extracellular proteins. These authors
found that the AgrD peptide produced by a given strain of S.
aureus activates its own agr locus but may inhibit the expression
of agr in other strains. It is suggested that this inhibitory effect
is correlated with the ability of a strain to compete with other
strains for sites of colonization or infection. This phenomenon
of AgrD-dependent cross-inhibition suggests the presence of
significant variability of the domain encoding for the AgrD
signal peptide (4). Indeed, it was shown that the autoinducer
(AgrD) and its modifying protein (AgrB) and receptor (AgrC)
harbored sequence variation. This affects the specificity of the
receptor-ligand interaction. On the basis of autoinducer-recep-
tor specificity, S. aureus can be divided into at least three
different agr groups (10).
Here, we report on the prevalence and nature of agrD poly-
morphism, as determined for a large collection of methicillin-
resistant S. aureus (MRSA) and methicillin-sensitive S. aureus
(MSSA) strains. agr restriction fragment length polymorphism
(RFLP) types were determined and classified into agr groups.
The dissemination of agr RFLP types between MRSA and
MSSA was studied. The potential relevance of agrD polymor-
phism in relation to colonization of distinct strain types in the
noses of intermittent versus persistent S. aureus carriers was
also analyzed.
MATERIALS AND METHODS
Strain collection. Strains of MRSA and MSSA (n 5 192) were pooled from
eight existing collections (Table 1). All strains were well typed by using a wide
variety of phenotypic and genotypic procedures: pulsed-field gel electrophoresis
(PFGE), randomly amplified polymorphic DNA (RAPD), binary typing, and
more. For cultivation, bacteria from glycerol stocks stored at 280°C were inoc-
ulated on Columbia III agar supplemented with 5% sheep blood (Becton Dick-
inson, Etten-Leur, The Netherlands) and incubated at 37°C for 24 h. All strains
were identified as S. aureus by standard microbiological methods (6). MSSA
strains from collection 1, isolated during the colonization studies, were derived
from nine healthy nasal carriers of S. aureus. When 5 to 8 out of the 10 serial
samples were positive, a person was identified as an intermittent carrier (n 5 6).
Persistent carriers (n 5 3) had 9 or 10 positive cultures out of the 10 samples
(17).
DNA isolation. Five to 10 colonies were suspended in a buffer containing 150
ml of 25 mM Tris-HCl (pH 8.0), 10 mM EDTA and 50 mM glucose. To prepare
spheroplasts, 75 ml of a lysostaphin solution at a concentration of 100 mg/ml
(Sigma Chemical Corporation, St. Louis, Mo.) was added. The mixture was
incubated for 1 h at 37°C. DNA isolation was done as described by Boom et al.
(3). Briefly, guanidine hydrothiocyanate was added for cell lysis and DNA was
purified by affinity chromatography with Celite (Janssen Pharmaceuticals,
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Beerse, Belgium). DNA was eluted from the Celite particles with 100 ml of 10
mM Tris-HCl (pH 8.0)–1 mM EDTA. The DNA concentration was estimated by
electrophoresis in the presence of ethidium bromide (0.3 mg/ml) (13). Stock
solutions of DNA were adjusted to a concentration of 50 ng/ml and stored at
220°C until further use.
PCR amplification of the agrD and partial agrC and agrB sequences. Approx-
imately 50 ng of DNA was amplified in a 100-ml reaction mixture consisting of 10
mM Tris-HCl (pH 9.0), 50 mM KCl, 2.5 mM MgCl2, 0.01% gelatin, and 0.1%
Triton X-100. Deoxyribonucleotide triphosphates (0.2 mM; Amersham Pharma-
cia Biotech, Roosendaal, The Netherlands) as well as 0.2 U of Taq polymerase
(SuperTaq; HT Biotechnology, Cambridge, United Kingdom) were present in
the reaction mixture. The locations of the primers agrB1 and agrC2 within the agr
locus are indicated in Figure 1. The National Center for Biotechnology Infor-
mation (NCBI) code and sequences of the primers (50 pmol of primer per
reaction) were as follows: agrC2, 59-CTT GCG CAT TTC GTT GTT TGA-39,
SAAGRAB sequence, nucleotides (nt) 3208 to 3189 (GenBank accession no.
X52543); agrB1, 59-TAT GCT CCT GCA GCA ACT AA-39, SAAGRAB se-
quence, nt 2142 to 2161. The PCR mixture was overlaid with 100 ml of mineral
oil to prevent evaporation. Amplification of the DNA fragments was performed
in a thermocycler (model 60; Biomed, Theres, Germany) with predenaturation at
94°C for 4 min, followed by 40 cycles of 1 min at 94°C, 2 min at 50°C, and 3 min
at 74°C and ending with a postelongation step at 74°C for 3 min. Amplicons were
purified by an additional ethanol precipitation step. The DNA pellet was lyoph-
ilized and redissolved in distilled water. The yield of amplicons was determined
by electrophoresis in the presence of ethidium bromide (0.3 mg/ml) (13).
Restriction of the PCR products. Restriction analysis of the amplicons was
performed with RsaI (Roche Molecular Biochemicals, Almere, The Nether-
lands) and AluI (Roche Molecular Biochemicals) according to the manufactur-
er’s instructions. The AluI and RsaI digests were visualized on 3% NuSieve
agarose gels (FMC Bioproducts, SanverTech, Heerhugowaard, The Nether-
lands) stained with ethidium bromide.
DNA sequencing and homology analysis. The 373 DNA-sequencing system
(Perkin-Elmer, Foster City, Calif.) was used for sequencing those amplicons that
generated a unique RFLP pattern. At first, amplicons were cloned with the
TOPO-TA cloning kit (Invitrogen, Leek, The Netherlands). Dye terminator
chemistry was applied (8, 14) using the manufacturer’s cycle sequencing protocol
(Amersham Pharmacia Biotech). Briefly, DNA was amplified in the presence of
a thermostable polymerase and primers agrB1 and agrC2. The extended, fluo-
rescently labeled fragments were separated by polyacrylamide gel electrophore-
sis. Labels were excited by a laser as they passed the detector near the bottom of
the gel. The first 100 nt were deleted because of unreliable sequencing results
(GenBank; SAAGRAB sequence no. 2100–2200 and 3160–3300, SA502a se-
quence no. 300–415 and 1420–1550, and RN8462 sequence no. 280–415 and
1420–1550). Reliability of the sequencing was assessed by including different
clones with the same RFLP pattern and checking the RFLP pattern versus the
primary sequence. These comparisons confirmed the lack of PCR errors (results
not shown). The sequences were compared with the data from the nucleotide and
protein sequence database of NCBI and analyzed for similarity with BLAST
(basic local alignment search tool) program (1). Sequence alignment and analysis
of sequence polymorphism among the different agr genes were performed with
Megalign Lasergene software (DNASTAR Inc., Madison, Wis.).
RESULTS
agr RFLP. The agr restriction patterns of 192 epidemiolog-
ically and genetically unique S. aureus strains were determined.
Only 12 unique-combination restriction patterns (AluI and
RsaI digests) (Fig. 2) were detected, indicating a relatively high
degree of sequence conservation. The frequency and distribu-
tion of the different RFLP patterns among the agr groups (see
also next section) (4) are outlined in Table 2. Among the
MRSA strains (71.4% of the total S. aureus collection), 10
distinct RFLP patterns (AA, CC, DD, DE, ED, FB, FE, GF,
GG, and HE) could be identified. The most predominant agr
RFLP types, AA and DE, represented 43.0 and 40.8% of the
MRSA strains, respectively. Based on DNA sequencing (see
also below) all types appeared to belong to agr group 1, except
for agr type GG (prevalence of 5.1%; agr group 3). Seven
different RFLP patterns (AA, BA, BB, DD, DE, ED, and FB)
TABLE 1. Characterization of the 192 S. aureus strains used in this study
Collection Geographic origin No. ofstrains Description of the collection Reference
1 Denmark 33 Nasal carriership (MSSA strains) 17
2 Worldwide 59 Geographically and temporally unrelated MRSA strains 7
3 USa 1 Type strain of a local MRSA outbreak in NYCc hospital 18
4 Spain and Portugal 11 Iberian (MRSA) clone 18
5 US 27 Community-acquired MRSA strains, isolated from outpatients from an NYC hospital 18
6b US 49 Multicenter collection of MRSA (n 5 32) and MSSA (n 5 17) strains 16
7 The Netherlands 10 Representative MRSA (n 5 6) and MSSA (n 5 4) strains from 10 outbreaks in Dutch
hospitals
19
8 US 2 MSSA strains obtained from 2 hospitalized patients (NYC) 18
a US, United States.
b Centers for Disease Control and Prevention, Atlanta, Ga.
c NYC, New York City.
FIG. 1. Schematic map of the S. aureus agr locus showing the amplified
region. The amplicon contained the variable sequence, defining the distinct agr
groups (4). Primers C2 and B1 were selected from the conserved sequences. The
GenBank nucleotide position numbers of the three agr sequences from the
control strains, representing the three agr groups, are indicated above the cor-
responding positions on the map.
FIG. 2. RFLP analysis of the agr locus. Amplified DNA was digested with
AluI, yielding patterns a to h (left) and with RsaI, producing patterns a to g
(right). Twelve different combined AluI-RsaI combination patterns were de-
tected. Lanes M, molecular size markers.
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were found among the MSSA strains of which AA (prevalence,
23.6%) and ED (prevalence, 36.4%) appeared to be the most
prevalent lineages. Apart from RFLP type BB (prevalence,
14.5%; agr group 2), all types were classified as belonging to agr
group 1. One Dutch MRSA strain (Table 1, collection 7) gen-
erated an abnormally sized amplicon. Sequencing revealed
that the Tn4001 transposon was inserted in the 59 part of the
agrC gene (inserted between positions 2546 and 2547 of the
SAAGRAB sequence). No phenotype analysis was performed
for this strain, so we cannot discuss the activity of this deviating
agr locus.
Sequence polymorphism in the agr locus. The nucleotide
sequences of the 12 unique agr RFLP types were determined
and compared with the GenBank data. The sequences of agr
RFLP types BB, DD, DE, ED, FB, and GG were obtained for
two or three different strains (Fig. 3 and 4). All agr RFLP types
could be classified into the three previously known agr groups
(Table 2). The vast majority (92%) of the agr RFLP types
belong to group 1. Two distinct agr RFLP types (BB and GG)
could be classified as groups 2 and 3, respectively. The fre-
quency and positions of mutations in the agr locus for the
unique RFLP types are displayed in Fig. 4. The positions and
numbers of point mutations for strains D45 (RFLP type FB),
K2-2 (RFLP type FB), and T11 (RFLP type CC) were similar.
The sequences of RFLP types DD, DE, ED, and FE are closely
related to the SAAGRAB sequence and rarely displayed a very
small number of mutations. The nucleotide sequence of strain
K1-65 (RFLP type HE) is identical to the SAAGRAB se-
quence (GenBank). Gain and loss of AluI and RsaI restriction
sites are shown in Fig. 4. RFLP polymorphism cannot be de-
duced completely from the data presented in Fig. 4, since the
AluI and RsaI restriction sites on both termini of the amplicon
were not included in the sequence analysis. The inter- and
intrasequence polymorphism of the agr groups is outlined in
Fig. 3A. The sequence variability within an agr RFLP type
ranged from 0 to 1% (types ED, DD, and FB). The distances
between agr RFLP types within an agr group varied from 0 to
4%. The sequence diversity between agr groups 1 and 3 was
20%, while the agr group 2 cluster differed by 26.8% from the
former two groups. The divergent variability among agrD, par-
tial agrC, and agrB genes is displayed in Fig. 3B to D, respec-
tively. The agrD sequence varied from 0 to 1% among the agr
types within each agr group, except for agr group 2 (type BB),
where the agrD gene varied from 5 to 7%. The first 600 nt of
the agrC 59 part varied from 0 to 6% among the different agr
RFLP types. The intragroup variability of the agrC gene
ranged from 22.6% for groups 1 and 3 to 28.8% for group 2.
The last 140 bp from the agrB 39 domain displayed a high level
of similarity (99 to 100%) among the diverse RFLP types. The
agrB sequence variability within the three distinct agr groups
ranged from 14% for groups 1 and 3 to 24.8% for group 2.
The amino acid sequences of all agr types studied displayed
variability values similar to those observed for the nucleotide
sequences (data not shown). The sequences of the amino acid
residues of the AgrD propeptide within the unique agr RFLP
types were compared and are displayed in Table 3. The group
1 AgrD propeptide sequence is completely conserved, except
for types ED and CC. One amino acid, located downstream the
signal peptide, was affected. A higher degree of variability was
detected within the group 2 AgrD propeptide sequence,
whereas only a single RFLP type was found. The AgrD signal
peptide of this group consists of nine amino acids and displays
homology with the AgrD nonapeptide sequence of Staphylo-
coccus epidermidis Tu¨3298 (Table 3) (12). The AgrD propep-
tide sequences were compared and are outlined in Fig. 5. agr
groups 1 and 2 displayed a high level of similarity upstream of
the AgrD signal peptide. The AgrD propeptide sequences of
agr groups 1 and 3 were conserved within and downstream of
the signal peptide.
agr polymorphism among S. aureus strains of nasal carriers.
The S. aureus strains (n 5 3), obtained from the volunteers
were analyzed for agr polymorphism, and the results were
compared with those obtained with other pheno- and genotyp-
ing methods (Table 4). Analysis of the agr polymorphism of the
S. aureus strains from the persistent carriers reveals concor-
dance with the results of the other typing techniques, except
for protein A polymorphism. S. aureus strains isolated over
several years from persistent carriers displayed an agr group
switch in two of three carriers studied. Carrier 84 switched
from agr group 1 to agr group 2, and carrier 126 switched from
agr group 2 to agr group 1. Such switches are also observed
among the intermittent carriers of S. aureus (see carriers 9
[switch from group 1 to 3] and 88 [switch from group 2 to 3]).
The agr RFLP types within a given agr group of a carrier
displayed the same level of variability as for RAPD analysis
and coagulase (coag) gene typing. agr polymorphism within a
single agr group of a persistent carrier was detected, as con-
firmed by a 3 to 4% divergence at the sequence level (data not
shown). A predominant genotype could be identified. The
pheno- and genotypically identical predominant strains
(RAPD type BBB, coag gene type 14B; Table 4) displayed agr
polymorphism (RFLP types AA and ED) but not agr group
switching.
DISCUSSION
The synthesis of S. aureus virulence factors is controlled by
a cell density-sensing system based on the action of a signal
peptide secreted in the environment by the organism itself.
When a strain enters the postexponential phase, it produces
signal peptides that may inhibit or induce the expression of the
agr operon in other strains, depending on the agr group of the
strain. The amino acid sequences of the ligand (AgrD) and
receptor (AgrC) for such mutually interfering strains differ
considerably. This phenomenon suggests the presence of se-
lectively variable domains (4) and points to intricate structure-
function relationships at the protein level. Structure-activity
TABLE 2. Frequency and distribution of agr RFLP patterns within agr groups of the well-typed epidemiologically unrelated MRSA (n 5 137)
and MSSA (n 5 55) strainsa
agr
group
No. of strains (MSSA/MRSA) with RFLP pattern:
AA BB BA CC DD DE ED FB FE GG GF HE
1 13/59 3/0 0/2 8/2 2/56 20/7 1/1 0/1 0/1 0/1
2 8/0
3 0/7
a Strains were genetically typed using PFGE, RAPD analysis, binary typing, mecA/Tn554 probing, or a combination thereof. For AluI eight individual RFLP patterns
(a to h; Fig. 2) were identified, whereas the use of RsaI allowed for the identification of seven RFLP patterns (a to g; Fig. 2). Overall, 12 combined patterns were defined.
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FIG. 3. Dendrograms displaying the cluster analysis of the intra- and extra-agr group sequence homologies from the 12 distinct agr RFLP patterns. The numbers
on the horizontal axes display the percentages of similarity between the primary sequences of the distinct RFLP patterns. (A) Clustering of the total amplicon
sequences; (B) clustering of the agrD sequences; (C) clustering of the agrC sequences; (D) clustering of the agrB sequences. agr group reference sequences were
obtained from the data bank of the NCBI. aNCBI code SAAGRAB, accession no. X52543; bNCBI code SA502a, accession no. AF001782; cNCBI code RN8462,
accession no. AF001783. The Tn4001 insertion within the agr sequence of strain R viii was deleted for cluster analysis.
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studies have demonstrated that the presence of a thiolactone
group and the biochemical structure of the signal peptide
(AgrD) are essential for stimulating biological activity (10).
Cross-inhibition is less dependent on the structure of the signal
peptide (12). Hypothetically, cross-inhibition of agr gene ex-
pression represents an example of bacterial interference that
could be associated with colonization resistance or even com-
petition of strains during infection.
agr clonality for MRSA and MSSA. A major part (84%) of
the MRSA strains harbored agr RFLP type AA or DE. The
FIG. 3—Continued.
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vast majority (98%) of RFLP type AA strains originated in the
United States and were isolated in the 1980s. The other RFLP
type (DE) is present in the majority (94%) of European strains
isolated in the early 1960s. This geographical and temporal
conservation of agr RFLP type among MRSA strains fits well
with former observations regarding the clonal population
structure of European and American MRSA (11). All MRSA
strains belong to agr group 1, except for a small cluster of
strains (n 5 7) originating in Ontario, Canada (agr group 3).
Ninety percent of the MSSA strains could be classified as agr
group 1 as well. The remaining eight strains were indexed as
agr group 2, and all had agr RFLP type BB. Strains that belong
TABLE 3. Comparative analysis of the amino acid sequence variability within the prevalent unique agr RFLP types and agr groupsa
agr group agr RFLP type Strain code Amino acid sequence of AgrD propeptide
1b
1 FB D45
1 AA D84
1 HE K1-65
1 FB K2-2
1 DE K2-59
1 DD K2-60
1 BA R i
1 ED R ii
1 DD R iii
1 ED R viii
1 CC T11
1 DD T14
1 DE T27
1 ED T28
1 FE T54
2b
2 BB D57
2 BB T22
2c
3b
3 GG D76
3 GG Riv
a The control sequences obtained from GenBank were as follows: agr group 1, SAAGRAB sequence, accession no. X52543; agr group 2, SA502a, accession no.
AF001782; agr group 3, RN8462, accession no. AF001783. The sequences of the AgrD signal peptides are boxed. The sequences were aligned by MegAlign software
(DNAStar). The signal peptide sequence of S. epidermidis Tu¨ 3298 was derived from the study of Otto et al. (12). Sequence differences are underlined.
b Control sequence.
c S. epidermidis signal peptide sequence.
FIG. 5. Comparative analysis of the AgrD propeptide sequences. Box, signal peptides; light grey, identical residues in all three sequences; dark grey, identical
residues in two sequences.
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to the latter group were geographically unlinked but geneti-
cally closely related. Strains appeared to be similar based on
phage, ribo-, and multilocus enzyme electrophoresis typing.
However, this strain cluster displayed diverged PFGE and
RAPD patterns as if its members had evolved over time (data
not shown). The index strain of a MRSA outbreak (strain
collection 7) harbored part (approximately 1,000 bp) of the
Tn4001 transposon sequence, an aminoglycoside resistance de-
terminant in S. aureus strains. Only the transposase gene was
inserted in the 59 part of agrC. The Tn4001 sequence was
absent in other outbreak strains. The potential effect of the
transposon insertion on the activity of the agr operon was not
analyzed and remains unclear, but it seems as if the 59 part of
agrC is not essential for staphylococcal viability.
agr polymorphism at the sequence level. The agr sequences
from the agr RFLP types present in our S. aureus strains could
be classified in one of the three different agr groups defined by
Ji et al. (4). The main part (92.2%) of the S. aureus strains
belong to agr group 1. Consequently, the evolutionary signifi-
cance of the other agr groups is unclear. The amino acid se-
quences of AgrD from agr groups 2 and 3 are clearly different
from that from agr group 1. Groups 2 and 3 both share do-
mains with group 1 but do not share domains with each other,
except for sequences which are present in all three agr groups.
The amino acid homology among the three different AgrD
propeptide sequences suggests recombination.
Cluster analysis of the DNA sequences determined for the
agr RFLP types demonstrated that agrD and parts of agrB and
agrC have different evolutionary clock speeds. The observed
stability of the agrD signal peptide sequence within each agr
group confirms the results from the biochemical study with
coagulase-negative staphylococci of Otto et al. (12) dealing
with the relevance of the AgrD structure with respect to the
ligand-receptor interaction specificity for agr activation. Over-
all, agr groups 1 and 3 are more closely related (80% sequence
homology) than agr groups 1 and 2 (74% sequence similarity).
Considering the agr sequences, there is no indication of major
recombination events. It is interesting to see that AgrC se-
quence variation exceeds that of AgrD. Thus it could be spec-
ulated that the diversity of the AgrC receptor protein has a
more profound influence than that of AgrD in the recognition
reaction between noncanonical AgrD and AgrC proteins. This
would imply that the reactivity of the peptides is largely defined
by receptor polymorphism and not autoinducer peptide vari-
TABLE 4. agr polymorphism among S. aureus strains isolated from both persistent and intermittent nasal carriersa
Person no. Strainno.
Date of isolation
(day-mo-yr)
agr
type
agr
group
RAPD
type
No. of protA
repeats
Coag gene
type
Phage
type
Persistent carriers
53 44 09-03-92 DD 1 DDD 4 9C 641
53 45 31-08-92 FB 1 AAA 7 12A 793
53 47 01-11-93 DD 1 GGG 10 10F 693
53 48 15-08-94 DD 1 GGG 9 10F 542
84 54 09-03-92 AA 1 JIH 8 15I 692
84 55 18-04-93 AA 1 JIH 7 15I 692
84 56 01-11-93 ED 1 BBB 5 14B 811
84 57 15-08-94 BB 2 KJI 9 9C 292
126 58 19-10-92 BB 2 LKC 8 11N 793
126 59 18-04-93 ED 1 BBB 7 14B 812
126 60 15-08-94 ED 1 BBB 7 14B 811
Intermittent carriers
85 61 24-02-92 AA 1 JIH 7 15I 311
85 62 09-03-92 ED 1 BBB 8 14B 812
85 63 06-01-93 ED 1 BBB 8 14B 232
85 64 15-08-94 AA 1 JIH 9 15I 362
2 69 25-06-92 ED 1 BBB 9 14B 813
2 70 19-10-92 ED 1 BBB 9 14B 691
2 71 18-04-93 AB 1 AAA 7 12A 793
2 72 14-02-94 ED 1 BBB 9 14B 811
9 73 25-06-92 ED 1 BBB 5 14B 811
9 74 19-10-92 BA 1 CCC 7 9C 292
9 75 01-11-93 BA 1 CCC 7 9C 233
9 76 15-08-94 GG 3 MLJ 5 —b 191
32 79 20-01-92 ED 1 BBB 3 14B 811
32 80 25-06-92 ED 1 BBB 3 14B 811
32 81 15-08-94 DD 1 NMK 9 9J 793
20 84 09-03-92 AA 1 PNC 8 10G 562
20 85 27-04-92 AA 1 CCC 10 9C 293
20 86 25-06-92 AA 1 BBB 10 14B 811
20 87 06-01-93 ED 1 AAA 7 12A 793
113 88 09-03-92 BB 2 JFH 7 10I 692
113 89 19-10-92 AA 1 BBB 10 14B 811
113 90 14-02-94 ED 1 OOL 9 9C 631
a Data on the carrier status and RAPD, protein A (protein A (protA), coag gene, and phage types are adapted from van Belkum et al. (17). The RAPD three-letter
code summarizes the typing results for the primer used (first letter, primer AP-1; second letter, primer AP-7; third letter, primer ERIC-2). Numbers of protein A repeats
were derived from an analysis of the so-called X region by PCR. Amplicons were digested with RsaI. The number of direct repeats in this region was determined after
electrophoresis. Coag gene types were derived from a PCR-RFLP analysis of the coag gene and subsequent detection of the amplicon with AluI. Phage types are given
in an abbreviated form according to standards applied in the Statens Seruminstitut, Copenhagen, Denmark.
b —, no restriction site for the amplicon.
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ability. However, this requires additional verification by bio-
logical experimentation.
agr incompatibility and colonization. We studied the possi-
ble role of bacterial interference in relation to nasal S. aureus
carriership. We therefore analyzed the agr locus polymorphism
and the subsequent assignment to agr “incompatibility” groups
(1, 2, and 3) among staphylococcal strains isolated from per-
sistent and intermittent carriers. In both persistent and inter-
mittent nasal carriers of S. aureus, strains with different genetic
profiles, includng those identified by RAPD analysis, coag gene
genotyping, and phage typing, and different agr groups alter-
nate over time. Since carriers of S. aureus rarely carry two
clones at the same time (17), agr grouping may well play a role.
However, contrary to previous suggestions summarized above
(4, 10), we here show that the carrier status is not restricted to
a single agr group. RFLP analysis of the agr locus closely
mimicked the results obtained with whole-genome typing. Al-
though the numbers of individuals included in the present
analysis are limited and although we did not determine bio-
logical agr activity, our data show both alternation and persis-
tence of agr types. This is not in favor of a prominent biological
function of the agr system in nasal colonization dynamics. This
observation is further supported by the fact that the vast ma-
jority of S. aureus strains belong to agr group 1.
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